Fetal Arrhythmia

  • Takekazu Miyoshi


Fetal arrhythmias present as an irregular cardiac rhythm and abnormal heart rate. Despite the theoretical advantage of fetoplacental circulation, rapid progression to hydrops is found in fetuses with tachyarrhythmia or bradyarrhythmia due to the limited heart rate reserve. Accurate diagnosis is essential for appropriate management of fetal arrhythmias, but this can be challenging since fetal electrocardiography is unavailable. Echocardiography plays a pivotal role in diagnosis and management of fetal arrhythmias. Most cases of fetal arrhythmia have a structurally normal heart with isolated premature contractions that often spontaneously resolve without medical treatment. There is a clear clinical consensus that maternal transplacental antiarrhythmic therapy for fetal tachyarrhythmia is effective. Complete atrioventricular block is irreversible. Dexamethasone and intravenous immunoglobulin have been used to prevent myocardial inflammation, but recent studies have not shown efficacy of these drugs for fetal bradyarrhythmias. Long QT syndrome manifests in several heart rate patterns and is associated with cardiac arrest and sudden death. Maternal intravenous magnesium is effective for ventricular tachycardia or torsades de pointes. This chapter reviews the different types of fetal arrhythmias and gives an overview of the current diagnostic techniques and treatment strategies.


Bradycardia Fetal arrhythmia Fetal treatment Prenatal diagnosis Tachycardia 


  1. 1.
    Saemundsson Y, Johansson C, Wenling S, Gudmundsson S (2011) Hepatic venous Doppler in the evaluation of fetal extrasystoles. Ultrasound Obstet Gynecol 37:179–183CrossRefGoogle Scholar
  2. 2.
    Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS (1996) Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 27:1736–1740CrossRefGoogle Scholar
  3. 3.
    Miyoshi T, Maeno Y, Sago H, Inamura N, Yasukouchi S, Kawataki M et al (2015) Fetal bradyarrhythmia associated with congenital heart defects - nationwide survey in Japan. Circ J 79:854–861CrossRefGoogle Scholar
  4. 4.
    Gudmundsson S, Huhta JC, Wood DC, Tulzer G, Cohen AW, Weiner S (1991) Venous Doppler ultrasonography in the fetus with nonimmune hydrops. Am J Obstet Gynecol 164(1 Pt 1):33–37CrossRefGoogle Scholar
  5. 5.
    Hornberger LK, Sahn DJ (2007) Rhythm abnormalities of the fetus. Heart 93:1294–1300CrossRefGoogle Scholar
  6. 6.
    Kleinman CS, Donnerstein RL, Jaffe CC, DeVore GR, Weinstein EM, Lynch DC et al (1983) Fetal echocardiography. A tool for evaluation of in utero cardiac arrhythmias and monitoring of in utero therapy: analysis of 71 patients. Am J Cardiol 51:237–243CrossRefGoogle Scholar
  7. 7.
    Fouron JC, Fournier A, Proulx F, Lamarche J, Bigras JL, Boutin C et al (2003) Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart 89:1211–1216CrossRefGoogle Scholar
  8. 8.
    Nii M, Hamilton RM, Fenwick L, Kingdom JC, Roman KS, Jaeggi ET (2006) Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart 92:1831–1837CrossRefGoogle Scholar
  9. 9.
    National Institute of Child Health and Human Development Research Planning Workshop (1997) Electronic fetal heart rate monitoring: research guidelines for interpretation. Am J Obstet Gynecol 177:1385–1390CrossRefGoogle Scholar
  10. 10.
    Miyoshi T, Sakaguchi H, Katsuragi S, Ikeda T, Yoshimatsu J (2015) Novel findings of fetal ectopic atrial tachycardia by cardiotocography. Ultrasound Obstet Gynecol 46:629–630CrossRefGoogle Scholar
  11. 11.
    Knudson JM, Kleinman CS, Copel JA, Rosenfeld LE (1994) Ectopic atrial tachycardia in utero. Obstet Gynecol 84:686–689PubMedGoogle Scholar
  12. 12.
    Leuthold A, Wakai RT, Martin CB (1999) Noninvasive in utero assessment of PR and QRS intervals from the fetal magnetocardiogram. Early Hum Dev 54:235–243CrossRefGoogle Scholar
  13. 13.
    Horigome H, Takahashi MI, Asaka M, Shigemitsu S, Kandori A, Tsukada K (2000) Magnetocardiographic determination of the developmental changes in PQ, QRS and QT intervals in the foetus. Acta Paediatr 89:64–67CrossRefGoogle Scholar
  14. 14.
    Stinstra J, Golbach E, van Leeuwen P, Lange S, Menendez T, Moshage W et al (2002) Multicentre study of fetal cardiac time intervals using magnetocardiography. BJOG 109:1235–1243CrossRefGoogle Scholar
  15. 15.
    Zhao H, Strasburger JF, Cuneo BF, Wakai RT (2006) Fetal cardiac repolarization abnormalities. Am J Cardiol 98:491–496CrossRefGoogle Scholar
  16. 16.
    Sonesson SE, Eliasson H, Conner P, Wahren-Herlenius M (2014) Doppler echocardiographic isovolumetric time intervals in diagnosis of fetal blocked atrial bigeminy and 2:1 atrioventricular block. Ultrasound Obstet Gynecol 44:171–175CrossRefGoogle Scholar
  17. 17.
    Donofrio MT, Moon-Grady AJ, Hornberger LK, Copel JA, Sklansky MS, Abuhamad A, Cuneo BF et al (2014) Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 129:2183–2242CrossRefGoogle Scholar
  18. 18.
    Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89:913–917CrossRefGoogle Scholar
  19. 19.
    Gilljam T, Jaeggi E, Gow RM (2008) Neonatal supraventricular tachycardia: outcomes over a 27-year period at a single institution. Acta Paediatr 97:1035–1039CrossRefGoogle Scholar
  20. 20.
    Wang JN, Wu JM, Tsai YC, Lin CS (2000) Ectopic atrial tachycardia in children. J Formos Med Assoc 99:766–770PubMedGoogle Scholar
  21. 21.
    Simpson JM, Sharland GK (1998) Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 79:576–581CrossRefGoogle Scholar
  22. 22.
    Jaeggi E, Öhman A (2016) Fetal and neonatal arrhythmias. Clin Perinatol 43:99–112CrossRefGoogle Scholar
  23. 23.
    Oudijk MA, Michon MM, Kleinman CS, Kapusta L, Stoutenbeek P, Visser GH et al (2000) Sotalol in the treatment of fetal dysrhythmias. Circulation 101:2721–2726CrossRefGoogle Scholar
  24. 24.
    Shah A, Moon-Grady A, Bhogal N, Collins KK, Tacy T, Brook M et al (2012) Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias. Am J Cardiol 109:1614–1618CrossRefGoogle Scholar
  25. 25.
    Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L et al (2011) Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation 124:1747–1754CrossRefGoogle Scholar
  26. 26.
    Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U (2002) Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 19:158–164CrossRefGoogle Scholar
  27. 27.
    Strasburger JF, Cuneo BF, Michon MM, Gotteiner NL, Deal BJ, McGregor SN et al (2004) Amiodarone therapy for drug-refractory fetal tachycardia. Circulation 109:375–379CrossRefGoogle Scholar
  28. 28.
    Bartalena L, Bogazzi F, Braverman LE, Martino E (2001) Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment. J Endocrinol Invest 24:116–130CrossRefGoogle Scholar
  29. 29.
    Ebenroth ES, Cordes TM, Darragh RK (2001) Second-line treatment of fetal supraventricular tachycardia using flecainide acetate. Pediatr Cardiol 22:483–487CrossRefGoogle Scholar
  30. 30.
    Cuneo BF, Ovadia M, Strasburger JF, Zhao H, Petropulos T, Schneider J et al (2003) Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome. Am J Cardiol 91:1395–1398CrossRefGoogle Scholar
  31. 31.
    Horigome H, Nagashima M, Sumitomo N, Yoshinaga M, Ushinohama H, Iwamoto M et al (2010) Clinical characteristics and genetic background of congenital long-QT syndrome diagnosed in fetal, neonatal, and infantile life: a nationwide questionnaire survey in Japan. Circ Arrhythm Electrophysiol 3:10–17CrossRefGoogle Scholar
  32. 32.
    Simpson JM, Maxwell D, Rosenthal E, Gill H (2009) Fetal ventricular tachycardia secondary to long QT syndrome treated with maternal intravenous magnesium: case report and review of the literature. Ultrasound Obstet Gynecol 34:475–480CrossRefGoogle Scholar
  33. 33.
    Berg C, Geipel A, Kohl T, Breuer J, Germer U, Krapp M et al (2005) Atrioventricular block detected in fetal life: associated anomalies and potential prognostic markers. Ultrasound Obstet Gynecol 26:4–15CrossRefGoogle Scholar
  34. 34.
    Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E (2010) The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 55:2778–2784CrossRefGoogle Scholar
  35. 35.
    Eliasson H, Sonesson SE, Sharland G, Granath F, Simpson JM, Carvalho JS et al (2011) Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patients. Circulation 124:1919–1926CrossRefGoogle Scholar
  36. 36.
    Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C et al (2011) Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 124:1927–1935CrossRefGoogle Scholar
  37. 37.
    Miyoshi T, Maeno Y, Sago H, Inamura N, Yasukohchi S, Kawataki M et al (2012) Evaluation of transplacental treatment for fetal congenital bradyarrhythmia: - nationwide survey in Japan. Circ J 76:469–476CrossRefGoogle Scholar
  38. 38.
    Saleeb S, Copel J, Friedman D, Buyon JP (1999) Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 42:2335–2345CrossRefGoogle Scholar
  39. 39.
    Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK (2004) Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 110:1542–1548CrossRefGoogle Scholar
  40. 40.
    Trucco SM, Jaeggi E, Cuneo B, Moon-Grady AJ, Silverman E, Silverman N et al (2011) Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol 57:715–723CrossRefGoogle Scholar
  41. 41.
    Kelly EN, Sananes R, Chiu-Man C, Silverman ED, Jaeggi E (2014) Prenatal anti-Ro antibody exposure, congenital complete atrioventricular heart block, and high-dose steroid therapy: impact on neurocognitive outcome in school-age children. Arthritis Rheumatol 66:2290–2296CrossRefGoogle Scholar
  42. 42.
    Cuneo BF, Strasburger JF, Yu S, Horigome H, Hosono T, Kandori A et al (2013) In utero diagnosis of long QT syndrome by magnetocardiography. Circulation 128:2183–2191CrossRefGoogle Scholar
  43. 43.
    Cuneo BF (2015) The beginnings of long QT syndrome. Curr Opin Cardiol 30:112–117CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Singapore 2019

Authors and Affiliations

  • Takekazu Miyoshi
    • 1
  1. 1.Clinical Research Support CenterMie University HospitalTsuJapan

Personalised recommendations